Precigen Inc (NASDAQ: PGEN) on Friday, plunged -4.39% from the previous trading day, before settling in for the closing price of $4.56. Within the past 52 weeks, PGEN’s price has moved between $0.65 and $5.22.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 25.76%. The company achieved an average annual earnings per share of 15.02%. With a float of $147.61 million, this company’s outstanding shares have now reached $297.85 million.
Precigen Inc (PGEN) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Precigen Inc is 50.46%, while institutional ownership is 27.55%. The most recent insider transaction that took place on Sep 04 ’25, was worth 69,000. In this transaction Director of this company bought 15,000 shares at a rate of $4.60, taking the stock ownership to the 217,841 shares. Before that another transaction happened on Aug 28 ’25, when Company’s Director bought 10,645 for $4.65, making the entire transaction worth $49,491. This insider now owns 202,841 shares in total.
Precigen Inc (PGEN) Earnings and Forecasts
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.09 earnings per share (EPS) for the period topping the consensus outlook (set at -0.09) by -0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
Precigen Inc (NASDAQ: PGEN) Trading Performance Indicators
Precigen Inc (PGEN) is currently performing well based on its current performance indicators. A quick ratio of 2.71 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 299.35.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.43, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.09 in one year’s time.
Technical Analysis of Precigen Inc (PGEN)
Compared to the last year’s volume of 3.92 million, its volume of 8.14 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 55.73%.
During the past 100 days, Precigen Inc’s (PGEN) raw stochastic average was set at 78.38%, which indicates a significant increase from 66.79% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.41 in the past 14 days, which was higher than the 0.17 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.41, while its 200-day Moving Average is $1.62. Nevertheless, the first resistance level for the watch stands at $4.56 in the near term. At $4.76, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.88. If the price goes on to break the first support level at $4.24, it is likely to go to the next support level at $4.12. Should the price break the second support level, the third support level stands at $3.92.
Precigen Inc (NASDAQ: PGEN) Key Stats
Market capitalization of the company is 1.30 billion based on 297,973K outstanding shares. Right now, sales total 3,930 K and income totals -126,240 K. The company made 860 K in profit during its latest quarter, and -26,640 K in sales during its previous quarter.
